We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WES:NYSEWestern Midstream Partners, LP Analysis

Data as of 2026-09-01 - not real-time

$48.10

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Western Midstream Partners, LP is priced at $48.10 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 3.2%. RSI sits at 53.3, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $45.80 and resistance at $50.07.
Valuation screens as fair: a P/E of 15.3 sits below the sector average of 21.6. Revenue is growing at 30.0% on a 29.0% profit margin. The 7.70% dividend yield looks stretched against payout coverage.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 19.0%, a beta of -0.07 and a maximum drawdown of 11.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.

Top Market Events

Updated Aug 5, 2026 0 - Reported second-quarter 2026 Net income attributable to limited partners of $394.Western Midstream Partners has delivered a very strong 259.Reported second-quarter 2026 Net income attributable to limited partners of $394.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 42.71
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 15.3 versus sector average of 21.6
  • Dividend yield of 7.70% looks stretched against payout coverage

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 15.3 versus sector average of 21.6
  • Dividend yield of 7.70% looks stretched against payout coverage
  • Profit margin of 29.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth30.00%
Profit Margin29.00%
P/E Ratio15.3
ROE34.11%
ROA7.49%
Debt/Equity207.38
P/B Ratio5.6
Op. Cash Flow$2.1B
Free Cash Flow$867.0M
Industry P/E21.6

Technical Analysis

TrendBullish
RSI53.3
Support$45.80
Resistance$50.07
MA 20$48.05
MA 50$46.38
MA 200$42.71
MACDBearish
VolumeDecreasing
Fear & Greed Index93.13

Valuation

Fair Value$51.00
Target Price$48.17
Upside/Downside0.14%
GradeFair
TypeBlend
Dividend Yield7.70%

Risk Assessment

Beta-0.07
Volatility19.00%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.